Last reviewed · How we verify
Venofer® — Competitive Intelligence Brief
marketed
Iron replacement agent
Hematology
Small molecule
Live · refreshed every 30 min
Target snapshot
Venofer® (Venofer®) — Azad Pharma AG. Venofer® is an iron sucrose complex that replenishes iron stores in patients with iron deficiency anemia, particularly those with chronic kidney disease on hemodialysis.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Venofer® TARGET | Venofer® | Azad Pharma AG | marketed | Iron replacement agent | ||
| Iron Sucrose (Venofer) | Iron Sucrose (Venofer) | American Regent, Inc. | marketed | Intravenous iron replacement agent | ||
| Vifor and EPO | Vifor and EPO | Kunshan First People's Hospital Affiliated to Jiangsu University | marketed | Iron replacement agent and erythropoiesis-stimulating agent (ESA) | Iron (ferric ion) and erythropoietin receptor (EPOR) | |
| High-dose ferric derisomaltose | High-dose ferric derisomaltose | China-Japan Friendship Hospital | marketed | Iron replacement agent | ||
| Iron Carboxymaltose | Iron Carboxymaltose | Albina Nowak, MD | marketed | Intravenous iron replacement agent | Iron(III) ion; transferrin and ferritin (iron-binding proteins) | |
| Ferric Carboxymaltose Injection | Ferric Carboxymaltose Injection | Sichuan Huiyu Pharmaceutical Co., Ltd | marketed | Iron replacement agent | Iron metabolism pathway; transferrin receptor | |
| Generic sodium ferric gluconate | Generic sodium ferric gluconate | University of Maryland, Baltimore | marketed | Iron replacement agent | Iron (Fe3+) delivery; hemoglobin and myoglobin synthesis |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Iron replacement agent class)
- University of Maryland, Baltimore · 2 drugs in this class
- Ain Shams University · 1 drug in this class
- American Regent, Inc. · 1 drug in this class
- Azad Pharma AG · 1 drug in this class
- CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
- China-Japan Friendship Hospital · 1 drug in this class
- Hallym University Medical Center · 1 drug in this class
- J. Uriach and Company · 1 drug in this class
- JW Pharmaceutical · 1 drug in this class
- Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Venofer® CI watch — RSS
- Venofer® CI watch — Atom
- Venofer® CI watch — JSON
- Venofer® alone — RSS
- Whole Iron replacement agent class — RSS
Cite this brief
Drug Landscape (2026). Venofer® — Competitive Intelligence Brief. https://druglandscape.com/ci/venofer. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab